- Tytuł:
- Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215)
- Autorzy:
- Źródło:
- In eClinicalMedicine December 2023 66
Czasopismo naukowe